Apyx Medical Corp SEC filings APYX

Apyx Medical Corp has 992 filings in SEC EDGAR's recent list, going back to Dec 21, 1995. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Apyx Medical Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 28, 2026 —
8-K Current report
Other events
Sep 29, 2026 Sep 29, 2026
8-K Current report
Officer or director change, Shareholder vote results
Aug 7, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Other events
Jul 24, 2026 Jul 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 21, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
DEF 14A Proxy statement Jun 26, 2026 Dec 31, 2025
4 Insider transaction Jun 17, 2026 Jun 15, 2026
8-K Current report
Material agreement
Jun 17, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
SD Specialized disclosure (conflict minerals) Jun 1, 2026 —
8-K Current report
Other events
May 21, 2026 May 21, 2026
8-K Current report
Other events
May 14, 2026 May 14, 2026
8-K Current report
Other events
May 11, 2026 May 11, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
10-K Annual report Mar 10, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 10, 2026 Mar 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Jan 29, 2026 Jan 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 20, 2026 —
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
EFFECT Filing Dec 16, 2025 —
8-K Current report
Bylaw or fiscal year change
Dec 12, 2025 Dec 8, 2025
CORRESP Letter to the SEC Dec 12, 2025 —
S-3 Shelf registration Dec 1, 2025 —
8-K Current report
Material agreement, Other events
Nov 19, 2025 Nov 17, 2025
424B5 Prospectus supplement Nov 18, 2025 —
424B5 Prospectus supplement Nov 17, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Shareholder vote results
Aug 13, 2025 Aug 7, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
DEF 14A Proxy statement Jun 25, 2025 Dec 31, 2024
PRE 14A Preliminary proxy statement Jun 13, 2025 Dec 31, 2024
SD Specialized disclosure (conflict minerals) May 30, 2025 —
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
8-K Current report
Other events
May 13, 2025 May 13, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Other events
Apr 29, 2025 Apr 29, 2025
10-K Annual report Mar 13, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 13, 2025 Mar 13, 2025
4/A Filing Mar 3, 2025 Aug 13, 2024
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Officer or director change
Feb 6, 2025 Jan 31, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
3 Initial insider ownership Jan 17, 2025 Nov 6, 2024
8-K Current report
Results of operations
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Jan 6, 2025 Jan 6, 2025
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
424B5 Prospectus supplement Nov 8, 2024 —
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Officer or director change, Other events
Nov 8, 2024 Nov 4, 2024
SC 13G Ownership over 5% (passive) Oct 31, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 15, 2024 —
4 Insider transaction Aug 13, 2024 Aug 13, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
4 Insider transaction Aug 12, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results
Aug 12, 2024 Aug 8, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
DEF 14A Proxy statement Jun 25, 2024 Dec 31, 2023
SD Specialized disclosure (conflict minerals) May 31, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
3 Initial insider ownership May 9, 2024 May 7, 2024
SC 13D/A Amended ownership over 5% (active) May 9, 2024 —
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
8-K Current report
Material agreement, Officer or director change
May 9, 2024 May 7, 2024
SC 13D Ownership over 5% (active) Apr 5, 2024 —
SC 13D Ownership over 5% (active) Apr 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Mar 25, 2024 —
10-K Annual report Mar 21, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 21, 2024 Mar 21, 2024
8-K Current report
Other events
Feb 21, 2024 Feb 21, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2024 —
SC 13G Ownership over 5% (passive) Jan 23, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 23, 2024 —
8-K Current report
Other events
Jan 22, 2024 Jan 22, 2024
4 Insider transaction Jan 11, 2024 Jan 10, 2024
4 Insider transaction Jan 11, 2024 Jan 10, 2024
4 Insider transaction Jan 11, 2024 Jan 10, 2024
4 Insider transaction Jan 11, 2024 Jan 10, 2024
8-K Current report
Results of operations
Jan 8, 2024 Jan 8, 2024
4 Insider transaction Dec 14, 2023 Dec 12, 2023
3 Initial insider ownership Dec 6, 2023 Dec 4, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 28, 2023 Nov 21, 2023
S-8 Employee stock plan registration Nov 16, 2023 —
8-K Current report
Officer or director change
Nov 16, 2023 Nov 9, 2023
S-8 Employee stock plan registration Nov 16, 2023 —
4 Insider transaction Nov 15, 2023 Nov 14, 2023
8-K Current report
Material agreement, Agreement ended, New debt
Nov 9, 2023 Nov 8, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Shareholder vote results
Aug 16, 2023 Aug 10, 2023
4 Insider transaction Aug 15, 2023 Aug 10, 2023
4 Insider transaction Aug 15, 2023 Aug 10, 2023
4 Insider transaction Aug 15, 2023 Aug 10, 2023
4 Insider transaction Aug 15, 2023 Aug 10, 2023
4 Insider transaction Aug 15, 2023 Aug 10, 2023
4 Insider transaction Aug 15, 2023 Aug 10, 2023
4 Insider transaction Aug 15, 2023 Aug 10, 2023
SC 13G Ownership over 5% (passive) Aug 14, 2023 —
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
4 Insider transaction Jul 19, 2023 Jul 12, 2023
4/A Form 4/a Jun 29, 2023 Jun 26, 2023
4 Insider transaction Jun 28, 2023 Jun 26, 2023
DEF 14A Proxy statement Jun 23, 2023 Dec 31, 2022
144 Notice of proposed sale Jun 21, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jun 13, 2023 —
4 Insider transaction Jun 9, 2023 Jun 6, 2023
SD Specialized disclosure (conflict minerals) May 31, 2023 —
SC 13G Ownership over 5% (passive) May 19, 2023 —
SC 13G Ownership over 5% (passive) May 12, 2023 —
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Material agreement
Apr 18, 2023 Apr 13, 2023
4 Insider transaction Mar 22, 2023 Jan 7, 2022
10-K Annual report Mar 16, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 16, 2023 Mar 16, 2023
8-K Current report
Material agreement
Mar 15, 2023 Mar 14, 2023
8-K Current report
Material agreement, New debt
Feb 24, 2023 Feb 17, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
4 Insider transaction Jan 13, 2023 Jan 11, 2023
4 Insider transaction Jan 13, 2023 Jan 11, 2023
4 Insider transaction Jan 13, 2023 Jan 11, 2023
4 Insider transaction Jan 13, 2023 Jan 11, 2023
SC 13G/A Amended ownership over 5% (passive) Jan 11, 2023 —
8-K Current report
Results of operations
Jan 10, 2023 Jan 10, 2023
EFFECT Filing Dec 2, 2022 —
S-3/A Filing Dec 2, 2022 —
CORRESP Letter to the SEC Nov 30, 2022 —
UPLOAD Letter from the SEC Nov 30, 2022 —
SC 13G Ownership over 5% (passive) Nov 23, 2022 —
S-3 Shelf registration Nov 22, 2022 —
SC 13G/A Amended ownership over 5% (passive) Nov 21, 2022 —
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
4 Insider transaction Aug 31, 2022 Aug 29, 2022
4 Insider transaction Aug 17, 2022 Aug 11, 2022
8-K Current report
Shareholder vote results
Aug 17, 2022 Aug 11, 2022
4 Insider transaction Aug 17, 2022 Aug 11, 2022
4 Insider transaction Aug 17, 2022 Aug 11, 2022
4 Insider transaction Aug 17, 2022 Aug 11, 2022
4 Insider transaction Aug 17, 2022 Aug 11, 2022
4 Insider transaction Aug 17, 2022 Aug 11, 2022
4 Insider transaction Aug 17, 2022 Aug 11, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Other events
Jul 18, 2022 Jul 18, 2022
4 Insider transaction Jul 12, 2022 Jul 11, 2022
4 Insider transaction Jul 11, 2022 Jul 11, 2022
4 Insider transaction Jul 11, 2022 Jul 5, 2022
4 Insider transaction Jul 11, 2022 Jul 6, 2022
SC 13G Ownership over 5% (passive) Jul 8, 2022 —
DEF 14A Proxy statement Jun 24, 2022 Dec 31, 2021
8-K Current report
Other events
Jun 13, 2022 Jun 7, 2022
SD Specialized disclosure (conflict minerals) May 27, 2022 —
8-K Current report
Other events
May 26, 2022 May 26, 2022
4 Insider transaction May 23, 2022 May 19, 2022
4 Insider transaction May 19, 2022 May 11, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
APYX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Clearwater, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
719135
Former names
BOVIE MEDICAL CORP (until Jan 2, 2019); BOVIE MEDICAL Corp (until Jan 2, 2019); AN CON GENETICS INC (until Jan 13, 1999)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.